As the global economy mends, the 2021 growth of High Affinity Nerve Growth Factor Receptor will have significant change from previous year. According to our (LP Information) latest study, the global High Affinity Nerve Growth Factor Receptor market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global High Affinity Nerve Growth Factor Receptor market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States High Affinity Nerve Growth Factor Receptor market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global High Affinity Nerve Growth Factor Receptor market, reaching US$ million by the year 2028. As for the Europe High Affinity Nerve Growth Factor Receptor landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main High Affinity Nerve Growth Factor Receptor players cover Array BioPharma Inc, Astellas Pharma Inc, AstraZeneca Plc, and Daiichi Sankyo Co Ltd, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of High Affinity Nerve Growth Factor Receptor market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
ASP-7962
AZD-7451
BNN-27
Cenegermin
CRB-0089
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Bile Duct Cancer
Papillary Thyroid Cancer
Low Back Pain
Lung Cancer
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Array BioPharma Inc
Astellas Pharma Inc
AstraZeneca Plc
Daiichi Sankyo Co Ltd
Dompe Farmaceutici SpA
Genzyme Corp
Handok Inc
Ignyta Inc
Loxo Oncology Inc
Merck & Co Inc
Nerviano Medical Sciences Srl
Plexxikon Inc
Proximagen Ltd
Rottapharm Biotech Srl
Sienna Biopharmaceuticals Inc
Tiziana Life Sciences Plc